Scientists Offer New Insight into Neuron Changes Brought About by Aging
Team Awarded $1.8 Million to Develop New Approaches to Lung Cancer Therapy
Middle School Student Raises Funds for Alzheimer’s Research at TSRI



Of Note

Raymond Moellering and Liron Bar-Peled Receive Cancer Research Grants

Raymond Moellering and Liron Bar-Peled, research associates in the Cravatt lab at The Scripps Research Institute (TSRI), have received awards from the Damon Runyon Cancer Research Foundation, a nonprofit organization supporting innovative early-career researchers.

Moellering is one of five 2014 recipients of the Dale F. Frey Award for Breakthrough Scientists, recognizing scientists who have completed a Damon Runyon Fellowship, have greatly exceeded the foundation's highest expectations and are most likely to make paradigm-shifting breakthroughs that transform cancer prevention, diagnosis and treatment, according to the award announcement. Moellering’s research focuses on the link between alteration of metabolic pathways and corresponding protein modifications that occur in cancer cells with the goals of understanding tumor progression and identifying new opportunities for therapeutic intervention.

Bar-Peled was named one of 15 new Damon Runyon Fellows, outstanding postdoctoral scientists conducting basic and translational cancer research in the laboratories of leading senior investigators across the United States. Bar-Peled is exploring how the protease Caspase-8 regulates T cell activation, which represents a critical step in the adaptive immune response to cancer.

Twelve scientists supported by the Damon Runyon Cancer Research Foundation have received a Nobel Prize. Each of the foundation’s award programs is extremely competitive, with fewer than 10 percent of applications funded.

Jintang Du Awarded Myotonic Dystrophy Foundation Fellowship

Jintang Du, research associate in the Gottesfeld lab, has been awarded a two-year fellowship from the Myotonic Dystrophy Foundation, a San Francisco-based nonprofit organization that supports, educates and advocates for people living with this form of muscular dystrophy.

Du’s research seeks to develop DNA-binding Py-Im polyamides (macromolecules with repeating units) to bind specific, identified CTG-CAG triplet repeats that cause myotonic dystrophy type 1.

Send comments to: mikaono[at]

Research Associates Raymond Moellering (right) and Liron Bar-Peled of the Cravatt lab have received early-career awards from the Damon Runyon Cancer Research Foundation. (Photo by Cindy Brauer.)